Author:
Liu Yu-Ru,Yin Peng-Nien,Silvers Christopher R.,Lee Yi-Fen
Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87–108,
https://doi.org/10.3322/caac.21262
(2015).
2. Steinberg, G. D., Trump, D. L. & Cummings, K. B. Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment. The Urologic clinics of North America 19, 735–746 (1992).
3. Chang, S. S. & Cookson, M. S. Radical cystectomy for bladder cancer: the case for early intervention. The Urologic clinics of North America 32, 147–155,
https://doi.org/10.1016/j.ucl.2005.01.001
(2005).
4. Cancer Facts and Figures. (American cancer Society, 2017).
5. von der Maase, H. et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 18, 3068–3077,
https://doi.org/10.1200/JCO.2000.18.17.3068
(2000).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献